Search - tctmd.com

Displaying 41 - 60 of 475

Sort: Relevancy | Date

News Daily News

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

L.A. McKeown

October 27, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Todd Neale

October 21, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

Caitlin E. Cox

September 20, 2024

News Conference News ESC 2024

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

Yael L. Maxwell

September 04, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Yael L. Maxwell

June 10, 2024

Advertisement

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

September 2024 Dispatch for the CV Team

August 2024 Dispatch for the CV Team

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

July 2024 Dispatch for the CV Team

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content